•   
  •   

World Hydroxychloroquine: Olivier Véran requests a revision of the prescription rules

18:05  23 may  2020
18:05  23 may  2020 Source:   nouvelobs.com

The acquisition of TFC by Olivier Létang becomes clearer

 The acquisition of TFC by Olivier Létang becomes clearer © Supplied by Sofoot Létang at the head of Téf? It is in any case the most serious track for the acquisition of the club of Olivier Sadran, eager to sell all or part of his baby since last January. According to La Dépêche , Oliver Létang is determined to buy the TFC for several months, and has just provided financial guarantees to the Toulouse boss.

  Hydroxychloroquine : Olivier Véran demande une révision des règles de prescription © Copyright 2020, L'Obs

The Minister of Health Olivier Véran asked the High Council for Public Health (HCSP) on Saturday to propose "within 48 hours a review of the derogatory prescription rules ”for various treatments such as hydroxychloroquine, after the publication of a study showing its ineffectiveness and its risks for Covid-19 patients.

"Following the publication in TheLancet of a study alerting to the ineffectiveness and risks of certain treatments of Covid-19 including hydroxychloroquine, I asked the HCSP to analyze it and offer me within 48 hours a review of the derogating prescription rules, "said the minister in a tweet.

Donald Trump reveals that he is taking hydroxychloroquine

 Donald Trump reveals that he is taking hydroxychloroquine © Brendan Smialowski US President Donald Trump answers questions from journalists from the White House May 18, 2020 US President Donald Trump revealed on Monday that he was taking 'hydroxychloroquine, a drug against malaria, the possible efficacy of which against the coronavirus has not been rigorously demonstrated at this stage. "I have been taking it for a week and a half (...) I hear a lot of extraordinarily positive things" about this drug, said Mr.

Following the publication in @TheLancet of a study alerting to the ineffectiveness and risks of certain treatments… https://t.co/tXrsomAhBe

—olivierveran (@Olivier Véran)

Outside clinical trials, France has already restricted the use of hydroxychloroquine (HCQ) in hospitals only and only for serious cases on the collegial decision of doctors. This molecule, derived from the antimalarial chloroquine, has known an unprecedented notoriety since the end of February since Pr Didier Raoult, of the University Hospital Institute (IHU) in Marseille, relayed a small, little detailed Chinese study, claiming that the chloroquine phosphate was showing signs of efficacy in patients with SARS-CoV2.

Didier Raoult: "This whole story will end like contaminated blood"

The effervescence around hydroxychloroquine then experienced a revival when American President Donald Trump became the apostle, to the point of take it daily as a preventive measure. In Brazil, President Jair Bolsonaro is convinced of its effects, yet unproven, to the point that the Ministry of Health on Wednesday recommended its use for all patients with mild illness.

Pelosi says 'morbidly obese' Trump taking hydroxychloroquine 'not a good idea'

  Pelosi says 'morbidly obese' Trump taking hydroxychloroquine 'not a good idea' Speaker Nancy Pelosi (D-Calif.) said Monday that it's "not a good idea" for President Trump to be taking hydroxychloroquine as a potential treatment for coronavirus. "I would rather he not be taking something that has not been approved by the scientists, especially in his age group and in his, shall we say, weight group, what is morbidly obese, they say," Pelosi said during an appearance on CNN's "Anderson Cooper 360.""So, I think that it's not a good idea.

Increased risk of death

Two studies, one Chinese and one French, published last week, however found that the HCQ did not significantly reduce the risks of admission to intensive care or death in patients hospitalized with pneumonia due at Covid-19.

And another study, with data on a total of 96,000 patients, published on Friday in "The Lancet", to which Olivier Véran alludes in his tweet , concluded that neither chloroquine nor HCQ show efficacy against Covid-19 in hospitalized patients. According to this study, these molecules even increase the risk of death and cardiac arrhythmia. According to this large study published Friday in the prestigious scientific journal, neither chloroquine nor its derivative hydroxychloroquine prove effective against Covid-19 in hospitalized patients, and these molecules even increase the risk of death and cardiac arrhythmia .

France bans hydroxychloroquine ... but Prof. Raoult persists and signs! .
© Supplied by La Tribune Didier Raoult. In a decree published in the Official Journal, the Ministry of Health repealed the provisions which, since the end of March, made it possible to prescribe this drug against Covid-19 by way of derogation, only in the hospital and only for severely ill patients , after a collegial decision by the doctors. Studies had already pointed out its ineffectiveness.

—   Share news in the SOC. Networks
usr: 0
This is interesting!